Acts Online
GT Shield

Pharmacy Act, 1974 (Act No. 53 of 1974)

Board Notices

A Pharmacist who provides Pharmacist-Initiated Management of Antiretroviral Therapy (PIMART) services in South Africa: Scope of Practice, Competency Standards and the Criteria for Accreditation of a Pharmacist Initiated Management of Antiretroviral Therapy (PIMART) Course

Part 2: Competency Standards for a Pharmacist who provides Pharmacist-Initiated Management of Antiretroviral Therapy (PIMART) Services

Domain 3: Implement Processes for the prevention of HIV transmission and infection via PrEP, safer conception and contraception, and prevention of mother to child transmission

 

INTRODUCTION

 

The competencies required in the domain to implement processes for the prevention of HIV transmission and infection.

 

3.1 Implement PrEP in the PIMART environment.
3.2 Conduct pregnancy screening and recommend contraception in the PIMART context.
3.3 Implement pre-conception management for HIV positive couples.

 

DOMAIN 3: IMPLEMENT PROCESSES FOR THE PREVENTION OF HIV TRANSMISSION AND INFECTION VIA PrEP, SAFER CONCEPTION AND CONTRACEPTION, AND PREVENTION OF MOTHER TO CHILD TRANSMISSION

COMPETENCIES

BEHAVIOURAL STATEMENTS
3.1 Implement PrEP in the PIMART environment
3.1.1 Interpreting and applying the steps in the treatment process.

Range: screening, initiation, follow-up, maintenance, adherence support, FAQs and stopping PrEP.

3.1.2 Implementing the PEP to PrEP transition, and the prevention continuum and failure referral.
3.1.3 Describing PrEP administration methods and components.
3.1.4 Describing PrEP regimen options and nomenclature.
3.1.5 Analysing the pharmacology, dosing, safety, toxicity monitoring and side effects of medicines recommended by NDoH for PrEP.
3.1.6 Describing PrEP indications, contra-indications, and practical application in the pharmacy context.
3.2 Conduct pregnancy screening and recommend contraception in the PIMART context
3.2.1 Carrying out a basic fertility intention screen and referring patients who wish to conceive.
3.2.2 Demonstrating an understanding of processing pregnancy test results.

Range: positive, STI and HIV screening, negative with pregnancy intent, negative without pregnancy intent.

3.2.3 Listing and describing the types of available contraceptives.

Range: classification, dosing, and efficacy.

3.2.4 Describing indications for contraception.

Range: women who may wish to conceive in the future, and women who do not wish to conceive at all, contraception eligibility, and general use in South Africa.

3.2.5 Describing the link between contraception and HIV.

Range: injectable link to incidence, HIV and contraception choices and safety, contraception impact on risk.
3.3 Implement pre-conception management for HIV positive couples
3.3.1 Describing key aspects to consider ensuring conception occurs safely, and knowledge of how to minimise the risks of partner acquiring HIV.
3.3.2 Describing methods used to ensure safe conception.

Range: ART, PrEP, VMMC, STI treatment, timed intercourse without the use of a condom and self-insemination.

3.3.3 Demonstrate application of couple counselling skills when working with discordant couples.
3.4 Demonstrate knowledge of PMTCT and the rationale for PMTCT programmes
3.4.1 Demonstrating knowledge of the MTCT risk and risk factors in South Africa.
3.4.2 Demonstrating knowledge of the ideal treatment pathway for PMTCT.
3.4.3 Demonstrating knowledge of the safety and efficacy of various pharmacological therapies in PMTCT.
3.4.4 Demonstrate knowledge of the factors that improve and impede adherence and retention in PMTCT interventions.
3.4.5 Demonstrating knowledge of appropriate viral load monitoring and responses in PMTCT.